{"count": 47, "results": [{"_id": "33179823", "pmid": 33179823, "title": "Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center.", "journal": "Pediatr Diabetes", "authors": ["Meyers AG", "Hudson J", "Cravalho CKL", "Matta ST", "Villalobos-Perez A", "Cogen F", "Chung ST"], "date": "2021-03-01T00:00:00Z", "doi": "10.1111/pedi.13148", "meta_date_publication": "2021 Mar", "meta_volume": "22", "meta_issue": "2", "meta_pages": "182-191", "score": 50272.973, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment and @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@ in youth: Findings from a large tertiary care referral center.", "citations": {"NLM": "Meyers AG, Hudson J, Cravalho CKL, Matta ST, Villalobos-Perez A, Cogen F, Chung ST. Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center. Pediatr Diabetes. 2021 Mar;22(2):182-191. PMID: 33179823", "BibTeX": "@article{33179823, title={Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center.}, author={Meyers AG and Hudson J and Cravalho CKL and Matta ST and Villalobos-Perez A and Cogen F and Chung ST}, journal={Pediatr Diabetes}, volume={22}, number={2}, pages={182-191}}"}}, {"_id": "39182908", "pmid": 39182908, "title": "Rethinking about Metformin: Promising Potentials.", "journal": "Korean J Fam Med", "authors": ["Kim K"], "date": "2024-08-23T00:00:00Z", "doi": "10.4082/kjfm.24.0156", "meta_date_publication": "2024 Aug 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50262.305, "text_hl": "The most common adverse reactions of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@, and @SPECIES_9606 @@@women@@@ tend to be more experienced than @SPECIES_9606 @@@men@@@. ", "citations": {"NLM": "Kim K. Rethinking about Metformin: Promising Potentials. Korean J Fam Med. 2024 Aug 23;():. PMID: 39182908", "BibTeX": "@article{39182908, title={Rethinking about Metformin: Promising Potentials.}, author={Kim K}, journal={Korean J Fam Med}}"}}, {"_id": "36909343", "pmid": 36909343, "pmcid": "PMC9996666", "title": "The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes", "journal": "Front Endocrinol (Lausanne)", "authors": ["Dixon SA", "Mishra S", "Dietsche KB", "Jain S", "Mabundo L", "Stagliano M", "Krenek A", "Courville A", "Yang S", "Turner SA", "Meyers AG", "Estrada DE", "Yadav H", "Chung ST"], "date": "2023-02-23T00:00:00Z", "doi": "10.3389/fendo.2023.1125187", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1125187", "score": 50261.625, "text_hl": "There were no differences in stool frequency, consistency, or composite @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@GI symptom@@@ scores between one week Phase 1 @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@/prebiotic, Phase 1 @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@/placebo, or one month Phase 2 @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@/prebiotic ( Figure 1 ). ", "citations": {"NLM": "Dixon SA, Mishra S, Dietsche KB, Jain S, Mabundo L, Stagliano M, Krenek A, Courville A, Yang S, Turner SA, Meyers AG, Estrada DE, Yadav H, Chung ST. The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes Front Endocrinol (Lausanne). 2023;14():1125187. PMID: 36909343", "BibTeX": "@article{36909343, title={The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes}, author={Dixon SA and Mishra S and Dietsche KB and Jain S and Mabundo L and Stagliano M and Krenek A and Courville A and Yang S and Turner SA and Meyers AG and Estrada DE and Yadav H and Chung ST}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1125187}}"}}, {"_id": "38115865", "pmid": 38115865, "pmcid": "PMC10728571", "title": "Microbiome differences related to metformin intolerance among Black individuals with diabetes, a pilot cross-sectional study", "journal": "Metabol Open", "authors": ["Fayfman M", "Gewirtz AT", "Delaroque C", "Blanco G", "Gibanica S", "Srinivasan S", "Chassaing B"], "date": "2023-09-15T00:00:00Z", "doi": "10.1016/j.metop.2023.100256", "meta_date_publication": "2023 Dec", "meta_volume": "20", "meta_issue": "", "meta_pages": "100256", "score": 50258.66, "text_hl": "Participants with mean age 59+-11, 58% female, were stratified into three groups: 1)intolerant: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intolerance in the past, not on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@; 2)partially intolerant: mild to moderate @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@, currently taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 3)tolerant: using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ without symptoms. ", "citations": {"NLM": "Fayfman M, Gewirtz AT, Delaroque C, Blanco G, Gibanica S, Srinivasan S, Chassaing B. Microbiome differences related to metformin intolerance among Black individuals with diabetes, a pilot cross-sectional study Metabol Open. 2023 Dec;20():100256. PMID: 38115865", "BibTeX": "@article{38115865, title={Microbiome differences related to metformin intolerance among Black individuals with diabetes, a pilot cross-sectional study}, author={Fayfman M and Gewirtz AT and Delaroque C and Blanco G and Gibanica S and Srinivasan S and Chassaing B}, journal={Metabol Open}, volume={20}, pages={100256}}"}}, {"_id": "33293761", "pmid": 33293761, "pmcid": "PMC7705076", "title": "Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)", "journal": "J Clin Biochem Nutr", "authors": ["Hashimoto Y", "Nakajima H", "Hata S", "Miyoshi T", "Hosomi Y", "Majima S", "Nakanishi N", "Senmaru T", "Osaka T", "Okada H", "Ushigome E", "Hamaguchi M", "Asano M", "Yamazaki M", "Fukui M"], "date": "2020-11-01T00:00:00Z", "doi": "10.3164/jcbn.20-100", "meta_date_publication": "2020 Nov", "meta_volume": "67", "meta_issue": "3", "meta_pages": "223-227", "score": 50255.973, "text_hl": "Thus, the primary outcome of this study will be the effect of the probiotic BBG9-1 on @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@, including @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ who use @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Hashimoto Y, Nakajima H, Hata S, Miyoshi T, Hosomi Y, Majima S, Nakanishi N, Senmaru T, Osaka T, Okada H, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study) J Clin Biochem Nutr. 2020 Nov;67(3):223-227. PMID: 33293761", "BibTeX": "@article{33293761, title={Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)}, author={Hashimoto Y and Nakajima H and Hata S and Miyoshi T and Hosomi Y and Majima S and Nakanishi N and Senmaru T and Osaka T and Okada H and Ushigome E and Hamaguchi M and Asano M and Yamazaki M and Fukui M}, journal={J Clin Biochem Nutr}, volume={67}, number={3}, pages={223-227}}"}}, {"_id": "37347114", "pmid": 37347114, "pmcid": "PMC10280986", "title": "Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial", "journal": "Front Endocrinol (Lausanne)", "authors": ["Wen Q", "Fang S", "Liang Y", "Tian Y", "Chen Y", "Yuan J", "Chen Q"], "date": "2023-06-06T00:00:00Z", "doi": "10.3389/fendo.2023.1156521", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1156521", "score": 50255.42, "text_hl": "COMB, combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_glucagon_like_peptide_1_(7_36) @CHEMICAL_MESH:C061970 @@@beinaglutide@@@; @GENE_SLTM @GENE_79811 @@@MET@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@. ", "citations": {"NLM": "Wen Q, Fang S, Liang Y, Tian Y, Chen Y, Yuan J, Chen Q. Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial Front Endocrinol (Lausanne). 2023;14():1156521. PMID: 37347114", "BibTeX": "@article{37347114, title={Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial}, author={Wen Q and Fang S and Liang Y and Tian Y and Chen Y and Yuan J and Chen Q}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1156521}}"}}, {"_id": "34665938", "pmid": 34665938, "pmcid": "PMC8902400", "title": "Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial", "journal": "J Diabetes Investig", "authors": ["Hata S", "Nakajima H", "Hashimoto Y", "Miyoshi T", "Hosomi Y", "Okamura T", "Majima S", "Nakanishi N", "Senmaru T", "Osaka T", "Okada H", "Ushigome E", "Hamaguchi M", "Asano M", "Yamazaki M", "Fukui M"], "date": "2022-03-01T00:00:00Z", "doi": "10.1111/jdi.13698", "meta_date_publication": "2022 Mar", "meta_volume": "13", "meta_issue": "3", "meta_pages": "489-500", "score": 50254.715, "text_hl": "Effects of probiotic Bifidobacterium bifidum G9-1 on the @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@ of @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: An open-label, single-arm, exploratory research trial", "citations": {"NLM": "Hata S, Nakajima H, Hashimoto Y, Miyoshi T, Hosomi Y, Okamura T, Majima S, Nakanishi N, Senmaru T, Osaka T, Okada H, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial J Diabetes Investig. 2022 Mar;13(3):489-500. PMID: 34665938", "BibTeX": "@article{34665938, title={Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial}, author={Hata S and Nakajima H and Hashimoto Y and Miyoshi T and Hosomi Y and Okamura T and Majima S and Nakanishi N and Senmaru T and Osaka T and Okada H and Ushigome E and Hamaguchi M and Asano M and Yamazaki M and Fukui M}, journal={J Diabetes Investig}, volume={13}, number={3}, pages={489-500}}"}}, {"_id": "36159225", "pmid": 36159225, "pmcid": "PMC9412858", "title": "Metformin toxicity: A meta-summary of case reports", "journal": "World J Diabetes", "authors": ["Juneja D", "Nasa P", "Jain R"], "date": "2022-08-15T00:00:00Z", "doi": "10.4239/wjd.v13.i8.654", "meta_date_publication": "2022 Aug 15", "meta_volume": "13", "meta_issue": "8", "meta_pages": "654-664", "score": 50254.254, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@: A meta-summary of case reports", "citations": {"NLM": "Juneja D, Nasa P, Jain R. Metformin toxicity: A meta-summary of case reports World J Diabetes. 2022 Aug 15;13(8):654-664. PMID: 36159225", "BibTeX": "@article{36159225, title={Metformin toxicity: A meta-summary of case reports}, author={Juneja D and Nasa P and Jain R}, journal={World J Diabetes}, volume={13}, number={8}, pages={654-664}}"}}, {"_id": "39256177", "pmid": 39256177, "title": "Metformin-associated lactic acidosis: a serious complication of a common drug.", "journal": "BMJ Case Rep", "authors": ["Malani KA", "Finn A"], "date": "2024-09-10T00:00:00Z", "doi": "10.1136/bcr-2024-260592", "meta_date_publication": "2024 Sep 10", "meta_volume": "17", "meta_issue": "9", "meta_pages": "", "score": 50252.95, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ (@DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@) is a rare and potentially life-threatening complication of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use. ", "citations": {"NLM": "Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ Case Rep. 2024 Sep 10;17(9):. PMID: 39256177", "BibTeX": "@article{39256177, title={Metformin-associated lactic acidosis: a serious complication of a common drug.}, author={Malani KA and Finn A}, journal={BMJ Case Rep}, volume={17}, number={9}}"}}, {"_id": "32157435", "pmid": 32157435, "title": "An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases.", "journal": "J Cancer Res Clin Oncol", "authors": ["Broadhurst PJ", "Hart AR"], "date": "2020-05-01T00:00:00Z", "doi": "10.1007/s00432-020-03177-y", "meta_date_publication": "2020 May", "meta_volume": "146", "meta_issue": "5", "meta_pages": "1369-1375", "score": 50252.414, "text_hl": "We aimed to justify and inform a future phase III trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ versus placebo on survival in inoperable @DISEASE_Carcinoma_Pancreatic_Ductal @DISEASE_MESH:D021441 @@@PDAC@@@ by documenting prevalence of @SPECIES_9606 @@@patients@@@ meeting eligibility criteria, @<m>DISEASE_Signs_and_Symptoms_Digestive</m> @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@ and PPI use. ", "citations": {"NLM": "Broadhurst PJ, Hart AR. An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases. J Cancer Res Clin Oncol. 2020 May;146(5):1369-1375. PMID: 32157435", "BibTeX": "@article{32157435, title={An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases.}, author={Broadhurst PJ and Hart AR}, journal={J Cancer Res Clin Oncol}, volume={146}, number={5}, pages={1369-1375}}"}}]}